Introduction {#s1}
============

Schistosomiasis, formerly called snail fever, is caused by the genus *Schistosoma*, particularly *S. mansoni, S. haematobium*, and *S. japonicum* (McManus et al., [@B20]), and it is considered a global neglected tropical diseases (NTDs) (McManus et al., [@B20]). As the second-most socioeconomically devastating parasitic disease after malaria, schistosomiasis causes hundreds of millions of infections in certain parts of Asia, Africa, and Latin America (Ross et al., [@B26]) and threatens the animal husbandry economy worldwide.

Eggs are regarded as the main pathogenic factor of schistosomiasis, and ova-granulomas develop in the tissues and organs of human and reservoir hosts (Schwartz and Fallon, [@B28]). The greatest number of egg granulomas of schistosomiasis develop at locations of maximal egg accumulation, including the intestine, liver and genitourinary tract (Ross et al., [@B26]). Diarrhea is common, as is occult blood in the feces. Eggs retained in the gut wall induce inflammation, hyperplasia, ulceration, micro abscess formation, and polyposis, but little is known about the relationship between schistosome infection and the composition of the gut microbiome. Fortunately, a recent study showed fecal microbiome differences between *S. haematobium* infected and uninfected children (Kay et al., [@B17]). Furthermore, two independent studies illustrated that *S. mansoni* infection is associated with an altered gut microbiome (Jenkins et al., [@B15]; Schneeberger et al., [@B27]). However, the role that egg granulomas of *S. japonicum* play in the gut microbiome of the mammalian host is still unclear.

To explore the possible role of *S. japonicum* ova-induced granulomas on the gut microbiome, we used a murine model of schistosomiasis, generated by challenge with cercaria of *S. japonicum*. The objectives of this study were: (1) to characterize the microbiota in the gut after damage from *S. japonicum* ova-induced granulomas and (2) to identify bacterial taxa that are associated with *S. japonicum* infection in different mouse strains and different disease phases.

Materials and Methods {#s2}
=====================

Parasite Preparation and Animal Studies
---------------------------------------

Female C57BL/6 and BALB/c mice (24 of each inbred strain) of 6 to 8 weeks of age were randomly divided into the following groups: Control (Ctrl), Acute phase (AP), and Chronic phase (CP). Each group of animals was housed in separate cages, and all mice were maintained in a 12/12 h light/dark cycle at the same temperature (25 ± 1.5°C, 50 ± 5% relative humidity controlled by automatic heating and ventilation devices) and fed standard mouse chow (purchased from HNSJA Co., Ltd., Changsha of China) and pure water (Zhao et al., [@B36]).

The cercariae of *S. japonicum* (Chinese strain) were obtained from freshwater snails (*Oncomelania hupensis*) that were purchased from the Jiangsu Institute of Parasitic Diseases, Eastern China. In the AP and CP groups, mice were each challenged with 35 ± 1 cercariae. At 42 days post-infection, feces were examined to confirm the infection. At 8 weeks post infection, the host entered the chronic infection stage (Ferrari and Moreira, [@B10]; Seki et al., [@B29]; Chen et al., [@B2]). Under sterile conditions, mice in the Ctrl and AP groups were sacrificed at day 45, and CP mice were sacrificed on day 65.

Pathologic Analysis
-------------------

For pathologic analysis, samples of the liver, spleen and intestine were obtained. The tissues were fixed in 10% buffered formalin, embedded in paraffin, sectioned at 4.0 μm, and stained with hematoxylin and eosin for microscopic observation (six tissue samples for each group and three slices for each tissue). All procedures were performed without serious complications. The slides were interpreted under a light microscope (Olympus, Tokyo, Japan). The initial macroscopic diagnosis was made by the parasitologists, and the final diagnosis was confirmed histopathologically.

Intestinal Content Sampling and DNA Extraction
----------------------------------------------

The feces and intestinal contents were collected under sterile conditions. In brief, on the day of sacrifice, the fresh feces were collected at the time of defecation by scooping the feces into a sterile 15 ml centrifuge tube. For collection of intestinal contents, the intestine was cut into two fragments at the ileocecal junction. The contents were eluted from both fragments of the intestine with 10 ml of sterile normal saline and collected in 15 ml tubes. The tubes were centrifuged at 4,000 rpm for 10 min, and the supernatant was discarded. The feces and intestinal contents from the same mice were mixed and frozen in liquid nitrogen for 15 s and stored at −80°C in the laboratory before shipment.

Samples were packaged with 15 kg dry ice and sent to a company (Novogene Bioinformatics Technology Co., Ltd. in Tianjin, China) where the samples were stored at −80°C until DNA extraction. Total bacterial DNA was extracted from approximately 400--600 mg of each sample using a PowerFecal™ DNA Isolation kit (MO BIO Laboratories, Carlsbad, CA, USA) according to the manufacturer\'s instructions, and was stored at −80°C before further analysis. The DNA concentration and purity was checked on 1% agarose gel, and the DNA was diluted to a 1 ng/μl working stock.

Amplification and Sequencing
----------------------------

The 16S rRNA genes of the distinct V4 region (515-806, 392 bp) were amplified using specific primers. Briefly, DNA was amplified by using the 515F and 806R primer set (515F: 5′-GTG CCA GCM GCC GCG GTA A-3′; 806R: 5′- GGA CTA CHV GGG TWT CTA AT-3′), which targets the V4 region of bacterial 16S rDNA, with the reverse primer containing a 6-bp error-correcting barcode unique to each sample. PCR was performed using the Phusion® High-Fidelity PCR Master Mix with GC Buffer containing Taq DNA polymerase premix (New England Biolabs LTD., Beijing, China). The reaction occurred under the following conditions: 94°C for 3 min (1 cycle); 94°C for 45 s, 50°C for 60 s, 72°C for 90 s (35 cycles), and a final step of 72°C for 10 min. The same volume of 1 × loading buffer (containing SYB green) was mixed with the PCR products and underwent electrophoresis on a 2% agarose gel for detection. Samples with a bright main strip between 400 and 450 bp were chosen for further experiments. PCR products were mixed in equi-density ratios and purified by using the QIAquick Gel Extraction Kit (QIAGEN, Dusseldorf, Germany).

Sequencing libraries were generated using the TruSeq® DNA PCR-Free Sample Preparation Kit (Illumina, San Diego CA, USA) following the manufacturer\'s recommendations, and index codes were added. The library quality was assessed on the Qubit@ 2.0 Fluorometer (Thermo Scientific) and Agilent Bioanalyzer 2100 system. Subsequently, the library was sequenced on an Illumina HiSeq 2500 platform, and 250 bp paired-end reads were generated.

Data Analysis
-------------

Sample paired-end reads were merged by using FLASH V1.2.7 (Magoc and Salzberg, [@B19]). Quality filtering of the raw sequences was performed with QIIMEV1.7.0. The chimera sequences were detected using the UCHIME algorithm (Edgar et al., [@B9]) and were removed (Haas et al., [@B12]). Then, the effective sequences were obtained. Sequences analysis was performed by using UPARSE software package (Edgar, [@B8]). Sequences with ≥ 97% similarity were assigned to the same OTUs. A representative sequence for each OTU was screened for further annotation. For each representative sequence, the GreenGenes Database (DeSantis et al., [@B5]) was used based on the RDP classifier Version 2.2 (Wang et al., [@B34]) algorithm to annotate taxonomic information. Multiple sequence alignments were conducted using the MUSCLE software (Edgar, [@B7]). OTU abundance information was normalized using a standard of sequence numbers corresponding to the sample with the fewest sequences. Subsequent analyses of alpha diversity and beta diversity were all performed based on this output normalized data.

The alpha diversity in each sample was estimated by Observed species, Chao1, Shannon, and Good-coverage. All these indices in the samples were calculated with QIIME and displayed with R software (Version 2.15.3). Beta diversity analysis was used to evaluate differences in samples regarding bacterial community composition. Beta diversity on (un)weighted UniFrac was calculated by QIIME. Principal Coordinates Analysis (PCoA) was displayed using the WGCNA package, stat packages, and ggplot2 package in R software. Unweighted Pair-group Method with Arithmetic Means (UPGMA) Clustering was performed as a type of hierarchical clustering method to interpret the distance matrix using average linkage and was conducted by QIIME. A Wilcox rank-sum test was used as a significance test of alpha diversity and beta diversity differences between sample groups. Linear discriminant analysis coupled with effect size (LEfSe) was performed to identify the bacterial taxa differentially represented between groups at the genus or higher taxonomy levels.

Statistical Analysis
--------------------

Statistical analysis for the gut microbiome in mice was performed as described above. For all other experiments, the data were validated and analyzed using Statistical Package for Social Science (SPSS) for Windows version 17.0 (SPSS Inc., Chicago, IL, USA). To test whether there was a significant difference between two or more groups of sampling units in C57BL/6 and BALB/c mice, Analysis of Similarities (ANOSIM), and Multiple Response Permutation Procedure (MRPP) were used (Sickle, [@B30]). Statistical significance was defined as a *P*-value less than 0.05.

Results {#s3}
=======

General Information and Pathological Analysis
---------------------------------------------

At Day 0, mice in the AP and CP groups were infected with cercariae of *S. japonicum*. At Day 42, mature eggs containing live miracidium of *S. japonicum* were detected in the feces by microscopy, confirming successful infection ([Figure 1](#F1){ref-type="fig"}). Compared with the Ctrl group, the morphology of the intestine, liver and spleen and the weight of the body, liver, and spleen were dramatically altered for both C57BL/6 and BALB/c infected mice ([Figure 1](#F1){ref-type="fig"}; [Supplementary Figure 1](#SM1){ref-type="supplementary-material"}). Furthermore, intestinal epithelial edema, inflammation, necrosis, and liver nodules were observed in the infected groups ([Figure 1](#F1){ref-type="fig"}; [Supplementary Figure 1](#SM1){ref-type="supplementary-material"}). Compared to the AP group of C57BL/6 and BALB/c mice (C57.AP and BA.AP), the intestinal diameter in the CP group of both mouse strains was significantly increased ([Figure 1](#F1){ref-type="fig"}). This usually results from intestinal obstruction, ulcer formation, hemorrhage, and perforation. The main pathomorphological change of the intestinal mucosa was the *S. japonicum* ova-induced granuloma ([Figure 1](#F1){ref-type="fig"}). Further pathological analysis demonstrated that egg granulomas were mainly detected in the submucosa, and only a small number of egg granulomas was found in the muscle layers in C57.AP and BA.AP. In the CP group, the egg granulomatous reactions were not only distributed in submucosa, but numerous egg granulomas had circulated and destroyed muscle layers ([Figure 1](#F1){ref-type="fig"}). Compared to the AP group, more neutrophils infiltrated around the egg granuloma in the CP group ([Figure 1](#F1){ref-type="fig"}).

![Microscopy visualization and pathological analysis of C57BL/6 and BALB/c mice with *Schistosoma japonicum* infection. For C57BL/6 and BALB/c mice, feces from groups Ctrl and AP at day 45 and CP on day 65 were obtained. The liver, spleen, intestine and feces from groups Ctrl and AP at day 45 and CP on day 65 were obtained. The blue arrow represents an *S. japonicum* egg. The red circle represents a small intestinal lesion. The egg granulomas of *S. japonicum* from the intestinal mucosa are indicated by the black frame.](fmicb-10-00352-g0001){#F1}

Overview of Sequencing Analysis
-------------------------------

One sample from the CP group of C57BL/6 mice was discarded due to low quality so that a total of 23 samples (8 Ctrl, 8 AP, 7 CP) from C57BL/6 mice and 24 samples (8 Ctrl, 8 AP, 8 CP) from BALB/c mice were finally collected for 16S rRNA sequencing. In total, 2,730,325 raw sequences from 47 samples were generated, and the number of sequences varied from a minimum of 31,688 sequences obtained in C57BL/6 mice during the chronic phase (CCP4), to a maximum of 69,693 sequences obtained during the chronic phase in BALB/c mice (BCP2, [Table 1](#T1){ref-type="table"}). The mean number of sequences per sample was 58,092 ± 9,688 (standard deviation, SD). The species accumulation curves indicated that species richness representation in all samples had approached the plateau phase, and it was unlikely that more observed species would be detected without additional samples ([Supplementary Figure 2A](#SM2){ref-type="supplementary-material"}). Similarly, the rarefaction curves demonstrated that species representation in individual specimens had approached a saturation number of the observed species, and it did not seem as though more OTUs would be obtained with additional sequencing efforts ([Supplementary Figure 2B](#SM2){ref-type="supplementary-material"}). After sequence trimming, quality filtering and checking for chimeras, a total of 2,578,303 high-quality sequences remained. The number of effective tags varied from a minimum of 26,199 tags obtained in BCP5 to a maximum of 66,089 tags obtained in BCP2, with an average length of 253 bases ([Table 1](#T1){ref-type="table"}). The GC content in these samples ranged from 52.76 to 55.46%, and the average was 54.26 ± 0.61% (SD). At a threshold of 97% identity, these high-quality sequences were assigned to 25,278 OTUs. Each sample had 54,858 sequences, 538 OTUs, and 469 observed species on average ([Table 1](#T1){ref-type="table"}). The results showed that the bacteria belonged to 16 phyla, 33 classes, 60 orders, 109 families, and 240 genera.

###### 

Operational taxonomic unit (OTU)-based diversity indexes in mice gut samples during infection.

  **Sample name**   **Group**   **Raw PE(\#)**   **Raw Tags(\#)**   **Clean Tags(\#)**   **Effective Tags(\#)**   **Base (nt)**   **Q30**    **GC (%)**   **Effective (%)**   **OTUs**   **Observed species**   **shannon**   **chao1**    **Goods coverage**
  ----------------- ----------- ---------------- ------------------ -------------------- ------------------------ --------------- ---------- ------------ ------------------- ---------- ---------------------- ------------- ------------ --------------------
  CC1               C57.Ctrl    62,246           61,755             61,224               59,312                   14,985,918      98.98      54.39        95.29               570        486                    6.292         525.276      0.997
  CC2                           53,227           52,890             52,432               50,680                   12,811,999      99.00      53.92        95.21               591        519                    5.758         636.404      0.996
  CC3                           40,057           39,756             39,424               37,849                   9,566,440       98.84      54.29        94.49               549        506                    6.279         577.400      0.997
  CC4                           57,482           57,138             56,704               54,690                   13,826,825      98.97      52.90        95.14               576        494                    4.602         559.632      0.997
  CC5                           64,641           64,143             63,561               61,700                   15,591,329      98.92      54.72        95.45               587        509                    6.441         567.263      0.997
  CC6                           65,626           65,124             64,641               62,730                   15,856,322      98.97      53.92        95.59               575        496                    5.627         539.359      0.997
  CC7                           68,762           68,300             67,711               66,001                   16,675,191      98.97      54.26        95.98               540        460                    5.565         531.143      0.997
  CC8                           53,049           52,704             52,226               50,684                   12,808,063      98.96      53.86        95.54               555        505                    6.003         602.020      0.996
  CAP1              C57.AP      57,887           57,453             56,960               55,080                   13,916,102      98.97      53.94        95.15               539        471                    5.644         508.143      0.997
  CAP2                          57,589           57,117             56,602               54,808                   13,836,112      98.86      55.15        95.17               577        502                    6.349         543.714      0.997
  CAP3                          67,559           67,036             66,465               64,671                   16,334,529      98.89      55.09        95.73               561        476                    5.343         522.480      0.997
  CAP4                          61,722           61,241             60,655               58,670                   14,813,426      98.89      54.43        95.06               540        438                    5.703         508.288      0.997
  CAP5                          69,494           69,009             68,480               65,657                   16,599,279      98.99      54.94        94.48               500        394                    4.582         489.192      0.996
  CAP6                          52,343           51,960             51,348               50,027                   12,695,014      98.95      53.91        95.58               555        516                    6.430         581.632      0.997
  CAP7                          63,355           62,869             62,350               59,812                   15,118,445      98.95      54.20        94.41               591        519                    6.652         580.158      0.997
  CAP8                          45,988           45,595             45,139               44,180                   11,159,420      98.79      55.46        96.07               511        462                    5.205         513.776      0.997
  CCP1              C57.CP      62,461           62,036             61,563               58,349                   14,750,706      98.99      52.76        93.42               520        436                    4.819         507.400      0.997
  CCP2                          64,117           63,679             63,227               61,538                   15,555,415      99.02      54.55        95.98               503        420                    4.558         465.310      0.997
  CCP3                          68,435           68,008             67,543               65,977                   16,681,493      99.04      54.52        96.41               480        378                    3.517         473.020      0.996
  CCP4                          31,688           31,426             31,166               30,402                   7,682,806       98.8       53.85        95.94               447        405                    5.415         438.549      0.998
  CCP5                          66,501           65,961             65,399               63,865                   16,163,855      98.88      55.42        96.04               543        455                    5.084         523.018      0.997
  CCP6                          65,609           64,987             64,437               62,111                   15,702,213      98.86      53.69        94.67               569        480                    5.868         528.456      0.997
  CCP7                          58,799           58,334             57,773               56,234                   14,216,112      98.82      54.37        95.64               568        498                    6.607         552.808      0.997
  BC1               BA.Ctrl     61,431           61,035             60,504               59,027                   14,911,767      98.93      53.82        96.09               507        424                    4.867         476.667      0.997
  BC2                           69,175           68,624             68,059               66,014                   16,687,060      98.90      54.11        95.43               564        485                    6.350         550.553      0.997
  BC3                           55,838           55,480             54,999               53,404                   13,503,677      98.96      54.48        95.64               557        475                    5.690         531.269      0.997
  BC4                           34,463           34,177             33,851               32,682                   8,262,139       98.81      54.35        94.83               503        466                    6.546         498.283      0.998
  BC5                           68,559           68,067             67,476               65,208                   16,484,146      98.93      53.75        95.11               543        479                    6.204         516.967      0.997
  BC6                           67,202           66,742             66,122               64,381                   16,277,889      98.88      54.57        95.80               551        482                    6.109         518.491      0.997
  BC7                           60,723           60,318             59,800               58,046                   14,673,119      98.92      53.81        95.59               536        461                    5.752         530.081      0.997
  BC8                           53,008           52,685             52,264               50,965                   12,881,134      98.99      54.35        96.15               506        455                    6.093         540.213      0.997
  BAP1              BA.AP       64,636           64,153             63,498               61,339                   15,498,643      98.85      53.76        94.90               571        503                    6.926         572.081      0.997
  BAP2                          53,235           52,842             52,374               49,906                   12,609,458      98.91      54.29        93.75               571        511                    6.497         588.233      0.997
  BAP3                          62,268           61,778             61,226               57,675                   14,564,826      98.91      54.07        92.62               591        522                    6.744         570.300      0.997
  BAP4                          53,458           52,984             52,468               50,340                   12,707,679      98.83      54.29        94.17               559        520                    6.819         578.000      0.997
  BAP5                          67,079           66,651             66,034               60,520                   15,296,635      98.91      53.62        90.22               558        468                    4.587         521.644      0.997
  BAP6                          62,581           62,093             61,573               55,425                   14,012,600      98.95      53.63        88.57               499        421                    5.407         487.279      0.997
  BAP7                          60,239           59,815             59,234               57,919                   14,635,439      98.85      54.48        96.15               571        498                    6.510         541.596      0.997
  BAP8                          50,375           49,933             49,497               47,460                   11,996,688      98.91      54.76        94.21               567        522                    6.243         588.750      0.997
  BCP1              BA.CP       34,534           34,279             33,957               33,028                   8,344,957       98.77      55.35        95.64               494        455                    5.671         484.057      0.998
  BCP2                          69,693           69,233             68,638               66,089                   16,709,132      98.97      52.77        94.83               487        420                    4.053         515.136      0.996
  BCP3                          55,751           55,309             54,806               53,346                   13,476,296      98.90      54.86        95.69               504        438                    6.555         474.849      0.998
  BCP4                          58,121           57,687             57,190               55,061                   13,914,775      98.96      54.44        94.74               473        408                    5.030         442.528      0.998
  BCP5                          40,336           38,617             26,718               26,199                   6,617,591       98.71      54.52        64.95               425        390                    5.284         436.406      0.998
  BCP6                          54,409           54,016             53,599               52,406                   13,247,321      98.87      54.92        96.32               542        469                    5.091         529.768      0.997
  BCP7                          63,040           61,192             60,283               57,207                   14,560,230      98.71      54.19        90.75               524        465                    5.587         522.130      0.997
  BCP8                          51,534           51,156             50,678               49,629                   12,539,299      98.79      54.61        96.30               528        485                    6.615         555.660      0.997
  Total                         2,730,325        2,707,387          2,671,878            2,578,303                651,759,514     4,648.43   2,550.34     4,430.89            25,278     22,047                 269.573       24,845.382   46.860
  Max                           69,693           69,233             68,638               66,089                   16,709,132      99.04      55.46        96.41               591        522                    6.926         636.404      0.998
  Mini                          31,688           31,426             26,718               26,199                   6,617,591       98.71      52.76        64.95               425        378                    3.517         436.406      0.996
  Average                       58,092           57,604             56,848               54,858                   13,867,224      98.90      54.26        94.27               538        469                    5.736         528.625      0.997
  SD                            9,688            9,669              10,216               9,776                    2,471,997       0.08       0.61         4.64                39         39                     0.788         43.734       0.000

*C57 and BA represent C57BL/6 and BALB/c mice, respectively; Ctrl, AP and CP represent Group Control, Acute phase and Chronic phase, respectively; Max, Mini and SD stand for maximum value, minimum value and Standard deviation, respectively*.

In total, the trends in OTU numbers from the Ctrl to the CP group were different between C57BL/6 and BALB/c mice. For C57BL/6 mice, the OTU number rapidly decreased immediately after infection compared to the Ctrl ([Table 1](#T1){ref-type="table"}). In contrast, the OTU trends in BALB/c mice increased to a peak in AP and then decreased to a valley in CP. Detailed characteristics of each sample are listed in [Table 1](#T1){ref-type="table"}. Venn diagram was created to compare the similarities and differences among the communities in the different groups and samples ([Supplementary Figure 3](#SM3){ref-type="supplementary-material"}). For individual samples, the maximum, minimum and mean unique OTUs were 36 in BC2, 3 in CCP3, and 15, respectively ([Supplementary Figure 3](#SM3){ref-type="supplementary-material"}).

Bacterial Community Composition and Structure Succession Analysis
-----------------------------------------------------------------

At the phylum level, the intestinal microbial communities in all samples were dominated by Firmicutes (58.87%), Bacteroidetes (18.67%), Proteobacteria (13.80%), and Verrucomicrobia (6.05%) ([Figures 2A,B](#F2){ref-type="fig"}). For individual groups, the dominant phylum had various patterns. Verrucomicrobia was significantly more abundant in C57.AP than in BA.AP (*P* = 0.011). In contrast, Firmicutes was significantly more abundant in the AP group of BALB/c than in C57BL/6 mice (*P* = 0.020). Analogously, Proteobacteria were present at a \> 4-fold higher abundance in C57.CP than in BA.CP (*P* = 0.002). In contrast, Verrucomicrobia were present at a \> 4-fold higher abundance in BA.CP than in C57.CP (*P* = 0.060). Several of the most abundant taxa from the Ctrl and CP groups gradually increased, particularly in BALB/c mice ([Figure 2B](#F2){ref-type="fig"}). However, the percentage of dominant taxa was dramatically decreased during infection. As the dominant taxon, the abundance of Firmicutes gradually decreased following infection. The abundance of Bacteroidetes dramatically increased on day 45 post-infection, but then decreased from day 65 onwards. The abundance of Proteobacteria gradually increased on day 45 and dramatically increased on day 65 post-infection in C57BL/6 mice ([Figure 2A](#F2){ref-type="fig"}), while the abundance of Proteobacteria throughout the infection had little change in BALB/c mice ([Figure 2B](#F2){ref-type="fig"}).

![Variation of bacterial community structure. The relative abundance of bacterial phyla and families present in the gut of C57BL/6 and BALB/c mice. Data shown represent the top 10 most abundant phyla and families, whereas low abundance and unclassified OTUs were grouped in "Other." Sample names refer to samples as described in [Table 1](#T1){ref-type="table"}. **(A)** Bacterial community structure variation at the phylum level in C57BL/6 mice; **(B)** Bacterial community structure variation at the phylum level in BALB/c mice; **(C)** Bacterial community structure variation at the family level in C57BL/6 mice; **(D)** Bacterial community structure variation at the family level in BALB/c mice. **(E)** Taxonomic heatmap of different groups at the genus level. Characteristic relative abundances of various genera present in the Control (C57.Ctrl, BA.Ctrl), Acute phase (C57.AP, BA.AP), and Chronic phase (C57.CP, BA.CP). The portrait and landscape stand for different group and species annotation information, respectively. The left pattern indicates a clustering tree at the level of genus. The above profile displays clustering trees among different groups. Each column represents a unique subject.](fmicb-10-00352-g0002){#F2}

For all 47 samples, the most common families were Lachnospiraceae (24.3%), Lactobacillaceae (20.0%), and Bacteroidales_S24-7_group (14.2%) ([Figures 2C,D](#F2){ref-type="fig"}). Ruminococcaceae (6.0%), Verrucomicrobiaceae (6.0%), Enterobacteriaceae (5.7%), Erysipelotrichaceae (4.6%), Desulfovibrionaceae (3.7%), and Bacteroidaceae (2.2%) were subdominant families. The dominant families in the Ctrl, AP, and CP groups of C57BL/6 and BALB/c mice are shown in [Figures 2C,D](#F2){ref-type="fig"}, respectively. Lactobacillaceae and Lachnospiraceae gradually decreased from the Ctrl group to the CP group for both mouse strains. The Bacteroidales_S24-7_group increased in abundance for these two strains and became the most abundant and the top two taxa on day 45 but decreased on day 65. Interestingly, the abundance of Ruminococcaceae changed only slightly from the Ctrl group to the CP group for different mouse strains. Surprisingly, the low abundance of Verrucomicrobiaceae in C57.Ctrl (0.08%) was dramatically increased to 15.43% in C57.AP and subsequently decreased to 3.68% in C57.CP ([Figure 2C](#F2){ref-type="fig"}). For BALB/c mice, the abundance of Verrucomicrobiaceae rapidly increased to 16.43% on day 65 post-infection from 0.07% in BA.AP ([Figure 2D](#F2){ref-type="fig"}).

Hierarchical clustering based on the abundance profile of the genera showed that the two strains of mice tended to group together under the same experimental conditions ([Figure 2E](#F2){ref-type="fig"}). Interestingly, non-infected control, and acute phase groups clustered together, whereas on the left of the heatmap, a separation was observed between the AP and CP groups. At the genus level, several taxa showed significant differences among the six groups. In [Figure 2E](#F2){ref-type="fig"}, the most common genus in each group is shown. The gut microbiota in C57.CP was characterized by higher amounts of *Oscillibacter, Helicobacter, Flavonifractor*, and *Peptoclostridium*, and decreased amounts of *Lachnospiraceae_NK4A136_group*. Compared with BA.Ctrl, OTUs belonging to *Bifidobacterium* and *Erysipelatoclostridium* were observed more frequently after infection in BA.AP, whereas *Sporosarcina, Staphylococcus*, and *Lachnospiraceae_UCG-001* were more abundant in the chronic phase BA.CP.

Comparison of Bacterial Community Within Groups
-----------------------------------------------

Alpha diversity was calculated, including Chao1, good coverage, observed species, and Shannon index ([Table 1](#T1){ref-type="table"}). The trends of alpha diversity metrics for gut samples from the Ctrl to CP were different between different mice strains. For C57BL/6 mice, OTU numbers, observed species, and Shannon and Chao1 index values declined from group C57.Ctrl to C57.CP. In contrast, these values increased in BA.AP and finally decreased thereafter in BA.CP. The results showed that the interquartile range of species diversity was increased from the Ctrl to AP and CP in both C57BL/6 and BALB/c mice ([Figures 3A,B](#F3){ref-type="fig"}). Outliers were only detected in group C57.Ctrl, BA.Ctrl, and BA.AP ([Figure 3B](#F3){ref-type="fig"}).

![Bacterial community comparison of different groups between uninfected mice and infected mice. Outliers were plotted as individual points. **(A)** Alpha diversity analysis based on the Chao1 index among groups in different mouse strains. **(B)** Alpha diversity analysis based on the observed species index among groups in different mouse strains. **(C)** Beta diversity analysis based on weighted UniFrac in different mouse strain.](fmicb-10-00352-g0003){#F3}

For Chao1 analysis ([Figure 3A](#F3){ref-type="fig"}), C57.Ctrl samples had a significantly higher value than C57.AP and C57.CP (*P* = 0.046, *P* = 0.001; Wilcox rank-sum test). For BALB/c mice, BA.AP samples had a significantly higher Chao1 value than BA.Ctrl and BA.CP, respectively (*P* = 0.044 and *P* = 0.002, respectively; Wilcox rank-sum test). For observed species analysis ([Figure 3B](#F3){ref-type="fig"}), C57.Ctrl samples had a significantly higher value than C57.CP (*P* = 0.001; Wilcox rank-sum test). For BALB/c mice, BA.AP samples had a significantly higher value than BA.Ctrl and BA.CP (*P* = 0.017 and *P* = 0.001, respectively; Wilcox rank-sum test). For Shannon diversity, a significant difference was only seen between AP and CP samples of BALB/c mice (*P* = 0.048; Wilcox rank-sum test).

Comparison of Bacterial Community Among Groups
----------------------------------------------

Based on weighted UniFrac ([Figure 3C](#F3){ref-type="fig"}), the beta diversity for gut samples from the Ctrl to CP were similar in both C57BL/6 and BALB/c mice. The values were increased from group C57.Ctrl to C57.CP. Groups C57.AP and C57.CP had a statistically significant increase in beta diversity compared with C57.Ctrl samples (*P* = 2e-06, *P* = 1.2e-05; Wilcox rank-sum test). BA.Ctrl samples had a significantly lower beta diversity than BA.AP and BA.CP (*P* = 0.0001 and *P* = 2e-06, respectively; Wilcox rank-sum test). This suggested that the range of beta diversity was more heterogeneous in the infected group than in the uninfected control in both C57BL/6 and BALB/c mice. In particular, the degree of dispersion in groups C57.AP and BA.CP was strongly influenced. Outliers were detected in groups C57.Ctrl and BA.Ctrl.

To better visualize the OUT diversity of mouse gut bacteria with a broader evolutionary context in these two strains, a maximum likelihood phylogeny of the top 10 species (relative abundance of OTUs) was constructed. In [Figure 4](#F4){ref-type="fig"}, a total of 101 OTUs were identified as 10 different species. Among these OTUs, 28 were classified as Ruminococcaceae_UCG-014 and 21 as Lachnospirace_NK4A136_group, which were differently distributed in the groups of C57BL/6 and BALB/c mice. Most OTUs occurred in all groups with different abundances.

![Phylogenetic relationships and Species annotation of Operational Taxonomic Units (OTUs). The inner band shows genera colored by OTUs, the next band shows the relative abundance of OTUs, and the outer band shows the annotation reliability distribution of OTUs. Overall abundance and the magnitude of the difference among genera are indicated by bars.](fmicb-10-00352-g0004){#F4}

On the PCoA plot, each symbol represents the gut microbiota of one group ([Figure 5](#F5){ref-type="fig"}). It is noteworthy that the microbiotas from the Ctrl group to the CP group were distinct between C57BL/6 and BALB/c mice ([Figure 5A](#F5){ref-type="fig"}). The relationships between community structures revealed by PCoA were further tested by comparing within-group weighted UniFrac distances in C57BL/6 and BALB/c mice ([Figure 5B](#F5){ref-type="fig"}). Consistent with the PCoA plot, the between-group distances were significantly higher than the within-group distances (ANOSIM, MRPP, *P* ≤ 0.01) for each group ([Supplementary Tables 1](#SM5){ref-type="supplementary-material"}, [2](#SM6){ref-type="supplementary-material"}). These data suggest that the gut microbial community structures between the two strains of mice were significantly different. Additionally, the 47 samples were clustered by UPGMA with an unweighted UniFrac matrix. It showed that C57BL/6 and BALB/c mice were obviously clustered into two independent clusters at the phylum level ([Supplementary Figure 4](#SM4){ref-type="supplementary-material"}). In each cluster, the main samples in Ctrl, AP, and CP groups were also clustered into subclusters.

![Two-dimensional principal coordinates analysis (PCoA) plot of unweighted **(A)** and weighted **(B)** UniFrac distance matrices for both intestinal contents and feces samples from C57BL/6 and BALB/c mice during infection. The bacterial community of the feces and intestinal contents from C57BL/6 mice in group C57.Ctrl, C57.AP, and C57.CP and from BALB/c mice in group BA.Ctrl, BA.AP, and BA.CP are shown. Sample names refer to samples as described in [Table 1](#T1){ref-type="table"}.](fmicb-10-00352-g0005){#F5}

Potential Biomarker Discovery
-----------------------------

To identify bacterial taxa that were significantly different between groups of C57BL/6 and BALB/c mice, LEfSe was performed on the taxa. It showed that the bacterial taxa were differentially represented among the different groups of C57BL/6 and BALB/c mice ([Figure 6](#F6){ref-type="fig"}). The potential biomarkers at different taxonomic levels in the groups of C57BL/6 and BALB/c mice were determined ([Figure 7](#F7){ref-type="fig"}). At the genus level, the biomarker with a significant difference between C57.AP and the other two groups in C57BL/6 mice was *Akkermansia*; the biomarkers showing significant differences between C57.CP and the other two groups in C57BL/6 mice were *Helicobacter* and *Bacteroides*. Several genera, including *Lactobacillus, Desulfovibrio*, and *Turicibacter*, were associated with the non-infected control in C57BL/6 mice ([Figure 6B](#F6){ref-type="fig"}). In BALB/c mice, bacteria from the genera *Bacteroides* and *Erysipelatoclostridium* were identified as markers of BA.AP. The genus *Akkermansia* was a marker of BA.CP. The genera *Lactobacillus* and *Desulfovibrio* were enriched in BA.Ctrl ([Figure 6C](#F6){ref-type="fig"}).

![LEfSe identified the most differentially abundant taxa in different groups of C57BL/6 and BALB/c mice. Only taxa meeting an LDA significance threshold \>4 are shown in the figures. **(A)** Histogram of linear discriminant analysis (LDA) score distribution among the six groups; **(B)** Histogram of LDA score distribution among three groups of C57BL/6 mice; **(C)** Histogram of LDA score distribution among three groups of BALB/c mice; **(D)** Histogram of LDA score distribution between the C57.Ctrl and C57.AP group; **(E)** Histogram of LDA score distribution between the C57.AP and C57.CP group; **(F)** Histogram of LDA score distribution between the BA.Ctrl and BA.AP group; **(G)** Histogram of LDA score distribution between the BA.AP and BA.CP group; **(H)** Histogram of LDA score distribution between the C57.AP and BA.AP groups. **(I)** Histogram of LDA score distribution between the C57.CP and BA.CP groups.](fmicb-10-00352-g0006){#F6}

![Cladogram of the most differentially abundant taxa in different groups of C57BL/6 and BALB/c mice. **(A)** Cladogram of the most differentially abundant taxa in six groups of C57BL/6 and BALB/c mice; **(B)** Cladogram of the most differentially abundant taxa in different groups of C57BL/6 mice; **(C)** Cladogram of the most differentially abundant taxa in different groups of BALB/c mice; **(D)** Cladogram of the most differentially abundant taxa between C57.Ctrl and C57.AP; **(E)** Cladogram of the most differentially abundant taxa between C57.AP and C57.CP; **(F)** Cladogram of the most differentially abundant taxa between BA.Ctrl and BA.AP; **(G)** Cladogram of the most differentially abundant taxa between BA.AP and BA.CP; **(H)** Cladogram of the most differentially abundant taxa between C57.AP and BA.AP; **(I)** Cladogram of the most differentially abundant taxa between C57.CP and BA.CP.](fmicb-10-00352-g0007){#F7}

Discussion {#s4}
==========

In this study, the gut microbial structure in C57BL/6 and BALB/c mice with *S. japonicum* ova-induced granulomas was studied. Both species accumulation curves and rarefaction curves gained from the OTU counts approximate the saturation level, indicating a relatively perfect coverage of the total and individual ecosystem diversity. Based on the alpha diversity analysis, we observed that the richness and diversity of the intestinal microbiota in fecal samples from both C57BL/6 and BALB/c mice had been noticeably changed after *S. japonicum* infection. The beta diversity analysis showed a significantly higher beta diversity in the infected group compared to the uninfected group of these two mouse strains. Consistent with this notion, an overall reduction in alpha diversity and a significant increase in beta diversity were found in the gut microbiota of *S. mansoni*-infected mice when compared to uninfected controls (Jenkins et al., [@B15]). A loss of microbial diversity in the intestine is also shown in several human intestinal and extraintestinal disorders, including inflammatory bowel disease (IBD), colorectal cancer (CRC), chronic liver diseases, type 2 diabetes, and asthma (Tilg et al., [@B32]). In the present study, the core gut microbiome at the phylum level in uninfected and infected mice was dominated by Firmicutes, Bacteroidetes and Proteobacteria, which are commonly found in the mouse model (Zheng et al., [@B37],[@B38]; Deng et al., [@B4]; Kim et al., [@B18]). Significant differences were found before and after infection. *S. japonicum*-treated mice had a significantly different microbiome composition compared to control groups of the two mouse strains based on beta diversity analysis. These findings indicated that *S. japonicum* ova-induced granulomas obviously influenced the microbial composition pattern in mice. This is consistent with a previous study in mice demonstrating the effect of helminth infection on the gut microbiota (Su et al., [@B31]). However, one study suggested that neither a *S. mansoni* infection nor praziquantel administration in children triggers a significant effect on the microbial composition, although some subtle modifications in the gut microbiome were observed (Schneeberger et al., [@B27]). The composition of the gut microbiome, especially in human beings, which is not only influenced by infections, but also by host genetic variation and environmental factors, such as nutrition, may explain this paradox (Kau et al., [@B16]; Blekhman et al., [@B1]).

Current data demonstrate that the relative abundance of dominant phyla and families show notable variation during the process of infection. Specifically, *S. japonicum* infection is connected with a relative decrease of Firmicutes in the feces compared with uninfected C57BL/6 mice. In contrast, *S. japonicum* cercaria exposure is related to an obvious relative increase of Bacteroidetes and Proteobacteria in the feces compared to untreated C57BL/6 mice. These changes in the abundance of Bacteroidetes and Firmicutes are also detected after human catestatin treatment in C57BL/6 mice (Rabbi et al., [@B25]). The altered gut microbial composition in mice associated with intestinal inflammation is quite similar to humans with IBD. The patients with IBD also have a comparatively low abundance of Firmicutes and relatively high abundance of Bacteroidetes (Hansen et al., [@B13]). In the members of the Firmicutes phylum, a loss of *Faecalibacterium prausnitzii* is correlated with an increased risk of postoperative recurrence of ileal Crohn\'s disease (Quévrain et al., [@B24]). In the phylum Bacteroidetes, *Bacteroides fragilis* toxin is associated with IBD, particularly in patients with active disease (Prindiville et al., [@B23]). However, the same variations, including the relative abundance of Firmicutes, Bacteroidetes, and Proteobacteria, are not observed in the feces of BALB/c mice. It demonstrates there is a considerable difference in the gut microbiome between the two mouse strains after *S. japonicum* infection. Moreover, similar results obtained from the PCoA and UPGMA dendrogram demonstrate that the gut microbial community structures after infection were significantly different between C57BL/6 and BALB/c mice. C57BL/6 mice have been a proposed model of *S. japonicum* schistosomiasis for insight into immunological disease process, such as granulomatous inflammation, due to their high level of inflammatory reactions (Mitchell et al., [@B21]; Hirata et al., [@B14]). Thus, C57BL/6 mice may be a useful rodent model for further studies of the schistosomal gut microbiome.

Several high-abundance phyla and families, such as Verrucomicrobia and Enterobacteriaceae, should not be ignored. In several diseases involving inflammation in the gut, including IBD and CRC, Enterobacteriaceae are one of the most commonly overgrown symbiotic bacteria (Zeng et al., [@B35]). Imbalances in Enterobacteriaceae are associated with IBD and CRC. As a common bacterial phylum detected in soil, Verrucomicrobia is also found in the marine environment (Freitas et al., [@B11]). However, little is known about its role in the murine gut. To address this issue, the microbial community composition from the *S. japonicum* infected mice was analyzed. Subsequently, Verrucomicrobia was detected as the dominant bacterial phylum in C57.AP and BA.CP. Consistently, a significant expansion in populations of *Verrucomicrobiaceae* (species *Akkermansia muciniphila*) was associated with *S. mansoni* infection (Jenkins et al., [@B15]). A similar result was found in humans following wide-spectrum antibiotic treatment (Dubourg et al., [@B6]). However, the role of this recently characterized phylum remains unclear. The current findings offer more insights into various host intestinal microbiomes after *S. japonicum* infection and demonstrate that microbiome analysis is potentially powerful for early accurate diagnosis of schistosomiasis and understanding of the pathogenic mechanism of disease progression.

As a broad-spectrum anthelmintic, praziquantel works effectively on cercaria and adult worms and is the recommended drug for schistosomiasis treatment (Mutapi et al., [@B22]). In conventional treatment, the role of gut microbiome has been ignored. Furthermore, the gut microbiome may disturb treatment by drugs. Additionally, when a drug is unreasonably utilized, drug resistance gradually appears (Vale et al., [@B33]). Thus, the abundance and composition of schistosomiasis- related bacteria should be evaluated during the treatment process. The results will support the hypothesis that *S. japonicum* treatment modulates the gut microbiota composition under pathophysiological conditions. In the current study, the gut microbiome was evaluated with 16S rRNA sequencing on a small scale. In addition to bacteria, other microorganisms, including viruses, protists, and fungi, are also considered members of the gut microbiome. Furthermore, the life cycle of *S. japonicum*, including cercaria, schistosomulum, adults and eggs, is extremely complex. Different stages of *S. japonicum* will influence the microbiome of the skin, lungs, intestine, and mesentery, which recently has been considered a novel organ (Coffey and O\'Leary, [@B3]). Thus, the sampling time and location will be fully considered in future studies. Moreover, metagenome sequencing for large-scale verification related to matched groups needs to be further validated.

In conclusion, our findings offer an insight into mouse gut microbial modulation after infection with *S. japonicum* cercaria. We observed an alteration in the gut microbial communities in response to *S. japonicum* treatment, which is more prominent in C57BL/6 than in BALB/c mice. The microbial community of the intestine could be used as a potential biomarker for the diagnosis of a *S. japonicum* infection and as an evaluation of the pathogenesis and progression of schistosomiasis.
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General information regarding uninfected and infected mice. The weights of the body, liver and spleen and spleen size in each group from C57BL/6 and BALB/c mice were obtained.
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Click here for additional data file.

###### 

Species diversity and richness evaluation of mouse gut samples during infection. **(A)** Species accumulation curves. The vertical axis shows the number of observed species that are expected to be found, after sequencing the number of samples shown on the horizontal axis. Curvature toward the horizontal indicates the increased sampling effort required to find species when only rare species remain to be discovered. **(B)** Rarefaction curves. The vertical axis shows the number of observed species that are expected to be found after sampling the number of tags or sequences shown on the horizontal axis. Curvature toward the horizontal indicates the increased sequencing effort required to find species when only rare species remain to be discovered.
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Shared operational taxonomic unit (OTU) analysis of the different communities. Venn diagrams showing the unique and shared OTUs in the different groups and communities. Group and sample names refer to groups and samples as described in [Table 1](#T1){ref-type="table"}.
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###### 

Hierarchical clustering of feces samples by the Unweighted Pair-group Method with Arithmetic Mean (UPGMA) according to their unweighted UniFrac matrix. Bar charts show the relative abundance of the main bacterial phyla found in each of the groups. Phyla representing \< 1% of the sequences in a group have been grouped as "other." Group names refer to groups as described in **Table 1**.
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Within- vs. Among-Group Dissimilarities analysis by Analysis of Similarities (ANOSIM).
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Within- vs. Among-Group Dissimilarities analysis via Multi Response Permutation Procedure (MRPP).
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Click here for additional data file.
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